Healthcare resource utilization by Respiratory Syncytial Virus disease patients

被引：0
|
作者：
Wandstrat, TL
Kaplan-Machlis, B
Beane, J
Dingivan, CA
机构：
[1] W Virginia Univ, Charleston, WV 25304 USA
[2] Medimmune Inc, Gaithersburg, MD 20878 USA
来源：
PEDIATRIC RESEARCH | 1999年 / 45卷 / 04期
关键词：
Respiratory Syncytial Virus; RSV; Respigam; RSVIG-IV; premature infant;
D O I：
10.1203/00006450-199904020-01054
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1037
引用
收藏
页码：177A / 177A
页数：1
相关论文
共 50 条
  • [1] Healthcare Resource Utilization by Respiratory Syncytial Virus Disease Patients
    Todd L Wandstrat
    Barbara Kaplan-Machlis
    Johnna Beane
    Christine A Dingivan
    Pediatric Research, 1999, 45 : 177 - 177
  • [2] INCIDENCE OF RESPIRATORY SYNCYTIAL VIRUS RELATED HEALTHCARE UTILIZATION IN THE UNITED STATES
    Tong, S.
    Amand, C.
    Kieffer, A.
    Kyaw, M.
    VALUE IN HEALTH, 2017, 20 (09) : A781 - A781
  • [3] Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants
    Ledbetter, Joel
    Brannman, Lance
    Wade, Sally W.
    Gonzales, Tara
    Kong, Amanda M.
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (02) : 139 - 147
  • [4] Healthcare Utilization Among Infants Covered by Medicaid and Newly Diagnosed With Respiratory Syncytial Virus
    Suh, Mina
    Movva, Naimisha
    Jiang, Xiaohui
    Reichert, Heidi
    Pastula, Susan T.
    Sacks, Naomi C.
    Frankenfeld, Cara
    Fryzek, Jon P.
    Simoes, Eric A. F.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
  • [5] HEALTHCARE RESOURCE USE AND ECONOMIC BURDEN ATTRIBUTABLE TO RESPIRATORY SYNCYTIAL VIRUS IN THE UNITED STATES
    Amand, C.
    Tong, S.
    Kieffer, A.
    Kyaw, M.
    VALUE IN HEALTH, 2017, 20 (09) : A796 - A797
  • [6] Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital
    Smithgall, Marie
    Maykowski, Philip
    Zachariah, Philip
    Oberhardt, Matthew
    Vargas, Celibell Y.
    Reed, Carrie
    LaRussa, Philip
    Saiman, Lisa
    Stockwell, Melissa S.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2020, 14 (03) : 247 - 256
  • [7] Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review
    Bechini, Angela
    Salvati, Cristina
    Bonito, Benedetta
    Del Riccio, Marco
    Stancanelli, Enrica
    Bruschi, Mario
    Ionita, Giulia
    Iamarino, Johanna Alexandra
    Bentivegna, Davide
    Buscemi, Primo
    Ciardi, Giulia
    Cosma, Claudia
    Stacchini, Lorenzo
    Conticello, Cristiana
    Bega, Manjola
    Paoli, Sonia
    Schirripa, Annamaria
    Bertizzolo, Lorenzo
    Muzii, Barbara
    Azzi, Maria Vittoria
    Parisi, Salvatore
    Trippi, Francesca
    Bonanni, Paolo
    Boccalini, Sara
    PUBLIC HEALTH, 2024, 227 : 103 - 111
  • [8] Severity of respiratory syncytial virus disease
    Fisher, RG
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (10) : 1030 - 1031
  • [9] PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS DISEASE
    Carrera, G.
    D'alterio, R.
    Leone, G.
    Zambetti, C.
    MINERVA PEDIATRICA, 2013, 65 (05) : 505 - 512
  • [10] Immunoprophylaxis of respiratory syncytial virus disease
    Sánchez, PJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (08) : 791 - 801
12345